A Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Four-Period Crossover Study to Assess the Effect of Single Doses of Corifollitropin alfa (150 mug and 240 mug) on QT/QTc Interval, Compared to Placebo, Using Moxifloxacin as a Positive Control, in Healthy Postmenopausal Women

Trial Profile

A Randomized, Double-Blind, Double-Dummy, Placebo-Controlled, Four-Period Crossover Study to Assess the Effect of Single Doses of Corifollitropin alfa (150 mug and 240 mug) on QT/QTc Interval, Compared to Placebo, Using Moxifloxacin as a Positive Control, in Healthy Postmenopausal Women

Completed
Phase of Trial: Phase I

Latest Information Update: 04 Dec 2017

At a glance

  • Drugs Corifollitropin alfa (Primary)
  • Indications Female infertility
  • Focus Adverse reactions
  • Most Recent Events

    • 04 Dec 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top